By 
                  Liz Highleyman
                  
                  Previous 
                  research has found that people with chronic 
                  hepatitis C virus (HCV) infection have an elevated risk 
                  for cardiovascular disease. While HCV has been linked to insulin 
                  resistance or diabetes -- known risk factors for heart disease 
                  -- it is also typically characterized by favorable blood lipid 
                  levels.
                  
                  In the present study, Aya Mostafa from AinShams University in 
                  Cairo and colleagues looked at the effect of this paradoxical 
                  risk profile on metabolism and atherosclerosis (hardening of 
                  the arteries and build-up of plaque) in the setting of HCV infection 
                  and clearance.
                
                This 
                  cross-sectional analysis included more than 1200 participants 
                  in Egypt aged 35 years or older. Within this study population, 
                  329 had chronic hepatitis C, 173 had cleared HCV infection, 
                  and 795 were never infected with HCV; a subset of 192, 115, 
                  and 187 participants, respectively, from the 3 groups underwent 
                  ultrasound imaging. 
                  
                  The investigators evaluated presence of diabetes, fasting blood 
                  glucose, lipid levels, and body fat deposition using ultrasound. 
                  Carotid intima-media thickness (IMT), or width of the inner 
                  lining of the carotid arteries supplying the brain, was used 
                  as a measure of atherosclerosis. 
                  
                   Results
                
                   
                    |  | Diabetes 
                      was more common among participants with chronic hepatitis 
                      C and cleared HCV infection (both with a prevalence of 10.1%) 
                      than among those who never had HCV (6.6%; P = 0.04 for chronic, 
                      0.08 for cleared). | 
                   
                    |  | The 
                      amount of mesenteric or visceral fat was greater in people 
                      with chronic hepatitis C (36.4 mm) and cleared infection 
                      (37.8 mm) relative to those never infected (32.7 mm; P = 
                      0.004 for chronic, < 0.0001 for cleared). | 
                   
                    |  | Low-density 
                      lipoprotein (LDL) cholesterol levels were lower in the chronic 
                      hepatitis C group (2.69 mmol/L; P < 0.001), but similar 
                      in those with cleared infection (3.56 mmol/L; P = 0.4) and 
                      those never infected (3.45 mmol/L). | 
                   
                    |  | Carotid 
                      IMT did not differ significantly according to HCV infection 
                      status, at 0.73, 0.71, and 0.71 mm, respectively. | 
                   
                    |  | After 
                      adjustmenting for traditional cardiovascular risk factors, 
                      however, IMT was greater in people with chronic infection 
                      (0.76 mm) compared with never infected individuals (0.70 
                      mm; P = 0.02). | 
                
                 
                  Based on these findings, the researchers proposed, "Hepatic 
                  function normalization with HCV clearance may account for reversal 
                  of favorable lipids observed with HCV infection." However, 
                  they added, glucose levels and visceral fat accumulation "appear 
                  less amenable to HCV resolution."
                  
                  "These different cardiovascular risk patterns may determine 
                  equivalent atherosclerosis risk by infection status," they 
                  suggested. "However, once these factors were accounted 
                  for, those with chronic infection had raised IMT, suggesting 
                  a direct effect of infection."
                  
                  Department of Community Medicine, Faculty of Medicine, AinShams 
                  University, Cairo, Egypt; Department of Tropical Medicine, Faculty 
                  of Medicine, Cairo University, Cairo, Egypt; Viral Hepatitis 
                  Reference Laboratory, National Hepatology and Tropical Medicine 
                  Research Institute, Cairo, Egypt; Institut Pasteur, Paris, France; 
                  Department of Metabolic Medicine, Imperial College NHS Healthcare 
                  Trust, London, UK; International Centre for Circulatory Health, 
                  National Heart & Lung Institute, Imperial College NHS Healthcare 
                  Trust, London, UK; Faculty of Medicine, Minia University, Minia, 
                  Egypt. 
                  
                  7/30/10
                Reference
                  A Mostafa, MK Mohamed, M Saeed, and others. Hepatitis C infection 
                  and clearance: impact on atherosclerosis and cardiometabolic 
                  risk factors. Gut (Abstract). 
                  June 28, 2010 (Epub ahead of print).